What We Do
SPARK Impact is one of the most active investors in the UK. Our focus is building world-class businesses that offer solutions to some of the global challenges that we face . . . Learn more
Portfolio
Here are some of our portfolio companies . . . Learn more
Contact Us
Interested in what we do?
Contact us today for more information . . . Learn more
TTS PHARMA LIMITED – ANNOUNCES CLOSING OF £10.3 MILLION FUNDRAISING AND NEW BOARD APPOINTMENT The completion of series B fundraise of £10.3 million The appointment of Paul Atherton as Chairman COMPLETION OF SERIES B FUNDRAISE May 23rd, 2019. TTS Pharma…
Brings Patent Portfolio to Five Issued U.S. Patents and over 20+ Pending Patent Applications - Fremont, Calif. and Oxford, UK, November 27, 2018 – Cerus Endovascular Ltd., a privately held medical device company engaged in the design and development of…
Gelmetix's gel can be delivered via a non-invasive procedure into the gaps left by degenerating discs to help restore functionality and relieve lower back pain University of Manchester spin-out company Gelmetix has secured £1.2 funding to help develop its non-surgical…
Fremont, California and Oxford, United Kingdom, November 13, 2018 – Cerus Endovascular Ltd., a privately held medical device company engaged in developing interventional neuroradiology devices and delivery systems to treat acute, life-threatening intracranial aneurysms, today announced enrollment of the first…
Who we work with
